| 0 |
GASTROSCHISIS |
1 |
0.0021 |
| 1 |
CONGENITAL HYDRONEPHROSIS |
1 |
0.0014 |
| 2 |
ALLERGIC COUGH |
1 |
0.0013 |
| 3 |
CORTISOL DECREASED |
1 |
0.0009 |
| 4 |
GROIN ABSCESS |
1 |
0.0008 |
| 5 |
JAUNDICE NEONATAL |
1 |
0.0005 |
| 6 |
INFUSION SITE BRUISING |
1 |
0.0005 |
| 7 |
REACTION TO DRUG EXCIPIENTS |
1 |
0.0005 |
| 8 |
ACCIDENT AT WORK |
1 |
0.0005 |
| 9 |
DEVICE INFUSION ISSUE |
1 |
0.0004 |
| 10 |
URINE ANALYSIS ABNORMAL |
1 |
0.0003 |
| 11 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
1 |
0.0003 |
| 12 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
1 |
0.0003 |
| 13 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
7 |
0.0002 |
| 14 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
1 |
0.0002 |
| 15 |
PULSE ABSENT |
1 |
0.0002 |
| 16 |
INCORRECT DOSAGE ADMINISTERED |
1 |
0.0002 |
| 17 |
PRODUCT COLOUR ISSUE |
1 |
0.0002 |
| 18 |
AUTISM SPECTRUM DISORDER |
1 |
0.0002 |
| 19 |
HEART RATE ABNORMAL |
1 |
0.0002 |
| 20 |
THERAPEUTIC RESPONSE CHANGED |
1 |
0.0002 |
| 21 |
INCORRECT DRUG ADMINISTRATION DURATION |
4 |
0.0001 |
| 22 |
MULTIPLE ALLERGIES |
1 |
0.0001 |
| 23 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 24 |
GASTRIC ULCER |
2 |
0.0001 |
| 25 |
EMPHYSEMA |
1 |
0.0001 |
| 26 |
THERAPEUTIC RESPONSE UNEXPECTED |
4 |
0.0001 |
| 27 |
DRUG DEPENDENCE |
14 |
0.0001 |
| 28 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 29 |
MENTAL IMPAIRMENT |
2 |
0.0001 |
| 30 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 31 |
HAEMATEMESIS |
2 |
0.0001 |
| 32 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 33 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 34 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 35 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 36 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 37 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 38 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 39 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 40 |
CHOKING |
1 |
0.0001 |
| 41 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 42 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 43 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 44 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 45 |
CHROMATURIA |
1 |
0.0000 |
| 46 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 47 |
MOOD ALTERED |
1 |
0.0000 |
| 48 |
PRODUCT USE IN UNAPPROVED INDICATION |
9 |
0.0000 |
| 49 |
ANGINA PECTORIS |
1 |
0.0000 |
| 50 |
HYPERSOMNIA |
1 |
0.0000 |
| 51 |
PREMATURE BABY |
1 |
0.0000 |
| 52 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 53 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 54 |
PRODUCT DOSE OMISSION |
2 |
0.0000 |
| 55 |
EYE PRURITUS |
1 |
0.0000 |
| 56 |
HYPOXIA |
1 |
0.0000 |
| 57 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 58 |
UNDERDOSE |
2 |
0.0000 |
| 59 |
THROAT IRRITATION |
1 |
0.0000 |
| 60 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 61 |
HYPOKALAEMIA |
1 |
0.0000 |
| 62 |
PRODUCT USE ISSUE |
4 |
0.0000 |
| 63 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 64 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 65 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 66 |
FLATULENCE |
1 |
0.0000 |
| 67 |
EYE IRRITATION |
1 |
0.0000 |
| 68 |
BONE PAIN |
1 |
0.0000 |
| 69 |
CATARACT |
1 |
0.0000 |
| 70 |
FEELING HOT |
1 |
0.0000 |
| 71 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 72 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 73 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 74 |
DIABETES MELLITUS |
1 |
0.0000 |
| 75 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 76 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 77 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 78 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 79 |
COVID-19 |
2 |
0.0000 |
| 80 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 81 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 82 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 83 |
CONTUSION |
1 |
0.0000 |
| 84 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 85 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 86 |
DYSPEPSIA |
1 |
0.0000 |
| 87 |
SINUSITIS |
1 |
0.0000 |
| 88 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 89 |
HAEMORRHAGE |
1 |
0.0000 |
| 90 |
HYPERTENSION |
2 |
0.0000 |
| 91 |
INFLUENZA |
1 |
0.0000 |
| 92 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 93 |
DRY SKIN |
1 |
0.0000 |
| 94 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 95 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 96 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 97 |
HEADACHE |
4 |
0.0000 |
| 98 |
DEATH |
5 |
0.0000 |
| 99 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 100 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 101 |
MUSCLE SPASMS |
1 |
0.0000 |
| 102 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 103 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 104 |
ANAEMIA |
1 |
0.0000 |
| 105 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 106 |
PRURITUS |
2 |
0.0000 |
| 107 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 108 |
OVERDOSE |
1 |
0.0000 |
| 109 |
FEELING ABNORMAL |
1 |
0.0000 |
| 110 |
NAUSEA |
3 |
0.0000 |
| 111 |
INSOMNIA |
1 |
0.0000 |
| 112 |
ANXIETY |
1 |
0.0000 |
| 113 |
OFF LABEL USE |
3 |
0.0000 |
| 114 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 115 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 116 |
ASTHENIA |
1 |
0.0000 |
| 117 |
FATIGUE |
2 |
0.0000 |
| 118 |
ARTHRALGIA |
1 |
0.0000 |
| 119 |
RASH |
1 |
0.0000 |
| 120 |
MALAISE |
1 |
0.0000 |
| 121 |
DIZZINESS |
1 |
0.0000 |
| 122 |
DYSPNOEA |
1 |
0.0000 |
| 123 |
DRUG INEFFECTIVE |
1 |
0.0000 |